abstract |
The present invention relates to the use of calpain inhibitor compounds and also to pharmaceutical compositions containing said calpain inhibitor compounds. Said compounds can be used in the treatment of a neurodegenerative pathology in humans. The invention also relates to other uses and pharmaceutical compositions containing the calpain inhibitor compounds, such as peptide keto-amides, peptide keto-acids, and peptide keto-esters. |